H. Lundbeck A/S et al v. Apicore US LLC
| Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and Takeda Pharmaceuticals America, Inc. |
| Apicore US LLC |
| 1:2018cv01034 |
| July 12, 2018 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 12, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Takeda Pharmaceutical Company Ltd., Other Affiliate Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc.; Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent Takeda Pharmaceutical Company Ltd., Other Affiliate Takeda Pharma A/S for Takeda Pharmaceuticals International AG filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. (ceg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (ceg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,144,884 B2; 8,476,279 B2; 8,722,684 B2; 8,969,355 B2; 9,227,946 B2; 9,861,630 B1. (ceg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/1/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 3/30/2021. (ceg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Apicore US LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2418695.) - filed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
